Updated April 25 at 4:56pm
Life Sciences
24 results total, viewing 1 - 10
Growth and molting rates of juvenile lobsters are likely to significantly decrease as oceans become more acidic due to climate change, according to the results of a study conducted by a University of Rhode Island doctoral student. more
Brown University ranked 19th in a list of the top 50 science research universities, according to Best College Reviews. more
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
Voyager Therapeutics, a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system, has entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
1 | 2 | 3 Next »